Clinical Trials for Dynavax Technologies

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Dynavax Technologies

Clinical Trials (2)

NCT07207408
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
PHASE2Recruiting
148 participants
Started: Sep 11, 2025 · Completed: Oct 16, 2026
1 condition2 sponsors3 locations
NCT06569823
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults
PHASE1/PHASE2Recruiting
440 participants
Started: Jun 17, 2024 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location